Literature DB >> 32817230

Men and Women Have Similar Neisseria gonorrhoeae Bacterial Loads: a Comparison of Three Anatomical Sites.

Brian M J W van der Veer1, Christian J P A Hoebe1,2, Nicole H T M Dukers-Muijrers2,3, Lieke B van Alphen1, Petra F G Wolffs4.   

Abstract

Neisseria gonorrhoeae is a common bacterial sexually transmitted infection (STI). Currently, there are limited data on the bacterial load in both men and women and on both genital and extragenital sites. Therefore, we quantified N. gonorrhoeae bacterial loads in a large population of women, heterosexual men, and men who have sex with men (MSM) at three different anatomical sites. N. gonorrhoeae-positive samples (n = 1265) of STI clinic consultations (n = 944) were tested for N. gonorrhoeae with the Roche Cobas 4800 system, and quantification cycle (Cq) values were used as an inversely proportional measure for N. gonorrhoeae bacterial load after interpolation from a standard curve. Bacterial loads were compared between sample materials and sexes using t tests. The following mean N. gonorrhoeae loads were observed: urine, 4.5 ± 1.0 log10 CFU/ml; vaginal swabs, 4.3 ± 1.1 log10 CFU/ml; anorectal swabs (women), 4.0 ± 1.2 log10 CFU/ml; anorectal swabs (men), 4.5 ± 1.3 log10 CFU/ml; oropharyngeal swabs (women), 2.8 ± 0.9 log10 CFU/ml; and oropharyngeal swabs (men), 3.2 ± 1.0 log10 CFU/ml. Oropharyngeal swabs had a significantly lower N. gonorrhoeae load (P < 0.001) than genital and anorectal samples. Loads did not differ between men and women. This is the first study that determined N. gonorrhoeae load in both women and men at three anatomical sites. The substantial N. gonorrhoeae load at all sample sites suggest that all sites may have transmission potential. However, the oropharyngeal site presents the lowest bacterial load. Men and women have a similar N. gonorrhoeae loads on separate anatomical sites, arguing for similar transmission potential and similar clinical relevance.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Neisseria gonorrhoeaezzm321990; bacterial load; extragenital; symptoms; transmission

Year:  2020        PMID: 32817230      PMCID: PMC7587094          DOI: 10.1128/JCM.01171-20

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

Review 1.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Evaluation of the cobas 4800 CT/NG Test for detecting Chlamydia trachomatis and Neisseria gonorrhoeae DNA in urogenital swabs and urine specimens.

Authors:  Manuel Parra-Sánchez; Jose Carlos Palomares; Samuel Bernal; María Trinidad González; Nieves Sivianes; Luis Pérez; Isabel Pueyo; Estrella Martín-Mazuelos
Journal:  Diagn Microbiol Infect Dis       Date:  2012-09-17       Impact factor: 2.803

3.  Experimental gonococcal urethritis and reinfection with homologous gonococci in male volunteers.

Authors:  K A Schmidt; H Schneider; J A Lindstrom; J W Boslego; R A Warren; L Van de Verg; C D Deal; J B McClain; J M Griffiss
Journal:  Sex Transm Dis       Date:  2001-10       Impact factor: 2.830

4.  Recommendations for the diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis, including extra-genital sites.

Authors:  Philip A Chan; Majorie Janvier; Nicole E Alexander; Erna M Kojic; Kimberle Chapin
Journal:  Med Health R I       Date:  2012-08

5.  Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development.

Authors:  M S Cohen; J G Cannon; A E Jerse; L M Charniga; S F Isbey; L G Whicker
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

Review 6.  Duration of gonorrhoea and chlamydia infection at the pharynx and rectum among men who have sex with men: a systematic review.

Authors:  Eric P F Chow; Shayne Camilleri; Christopher Ward; Sarah Huffam; Marcus Y Chen; Catriona S Bradshaw; Christopher K Fairley
Journal:  Sex Health       Date:  2016-06       Impact factor: 2.706

7.  Chlamydia trachomatis testing among young people: what is the role of stigma?

Authors:  Kevin A T M Theunissen; Arjan E R Bos; Christian J P A Hoebe; Gerjo Kok; Stan Vluggen; Rik Crutzen; Nicole H T M Dukers-Muijrers
Journal:  BMC Public Health       Date:  2015-07-14       Impact factor: 3.295

8.  2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.

Authors:  C Bignell; M Unemo
Journal:  Int J STD AIDS       Date:  2013-02       Impact factor: 1.359

9.  What is needed to guide testing for anorectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women and men? Evidence and opinion.

Authors:  Nicole H T M Dukers-Muijrers; Julius Schachter; Genevieve A F S van Liere; Petra F G Wolffs; Christian J P A Hoebe
Journal:  BMC Infect Dis       Date:  2015-11-17       Impact factor: 3.090

10.  Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016.

Authors:  Jane Rowley; Stephen Vander Hoorn; Eline Korenromp; Nicola Low; Magnus Unemo; Laith J Abu-Raddad; R Matthew Chico; Alex Smolak; Lori Newman; Sami Gottlieb; Soe Soe Thwin; Nathalie Broutet; Melanie M Taylor
Journal:  Bull World Health Organ       Date:  2019-06-06       Impact factor: 9.408

View more
  4 in total

1.  Despite Excellent Test Characteristics of the cobas 4800 CT/NG Assay, Detection of Oropharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae Remains Challenging.

Authors:  J M van Niekerk; B M J W van der Veer; C J P A Hoebe; J van de Bovenkamp; C van Herk; I H M van Loo; L B van Alphen; P F G Wolffs
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

2.  Pharmacodynamic Evaluation of Zoliflodacin Treatment of Neisseria gonorrhoeae Strains With Amino Acid Substitutions in the Zoliflodacin Target GyrB Using a Dynamic Hollow Fiber Infection Model.

Authors:  Susanne Jacobsson; Daniel Golparian; Joakim Oxelbark; Francois Franceschi; David Brown; Arnold Louie; George Drusano; Magnus Unemo
Journal:  Front Pharmacol       Date:  2022-04-14       Impact factor: 5.988

3.  Rapid Detection of Neisseria gonorrhoeae Genomic DNA Using Gold Nanoprobes Which Target the Gonococcal DNA Uptake Sequence.

Authors:  Ella Carter; Sean A Davis; Darryl J Hill
Journal:  Front Cell Infect Microbiol       Date:  2022-07-08       Impact factor: 6.073

4.  Pharmacodynamic Evaluation of Dosing, Bacterial Kill, and Resistance Suppression for Zoliflodacin Against Neisseria gonorrhoeae in a Dynamic Hollow Fiber Infection Model.

Authors:  Susanne Jacobsson; Daniel Golparian; Joakim Oxelbark; Emilie Alirol; Francois Franceschi; Tomas N Gustafsson; David Brown; Arnold Louie; George Drusano; Magnus Unemo
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.